Citius Oncology, Inc. (CTOR)

NASDAQ: CTOR · Real-Time Price · USD

0.5577

+0.0482 (9.46%)

Nov 9, 2026, 2:10 PM EST - Market open

Citius Oncology Financials Overview

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Operating Income	-47.47	-23.52	-20.57	-12.12	-9.71
Net Income	-46.06	-24.76	-21.15	-12.7	-10.87
Earnings Per Share	-0.49	-0.34	-0.31	-0.19	-0.32
EPS Growth	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Cash & Investments	16.56	3.92	0	-	-
Total Debt	10.21	3.8	3.8	-	-
Net Cash (Debt)	6.35	0.12	-3.8	-	-
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	0.07	0.00	-0.06	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Operating Cash Flow	-19.39	-5.49	0.13	-	-
Free Cash Flow	-19.39	-5.49	0.13	-	-
Free Cash Flow Growth	-	-	-	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 9, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Forward PE	-	89.00	-	-	-